Sales were driven by a strong flu season and growth in Asia-Pacific business.
The firm also received approval from the Singapore Health Sciences Authority to market the Unyvero blood culture cartridges.
The PCR-based cartridge is designed to detect 21 pneumonia pathogens and 19 genetic markers of antibiotic resistance, and runs on the company's Unyvero system.
IDbyDNA and ARUP Labs will offer their first test for pneumonia through ARUP's established clinical network in the coming weeks.
UK clinicians are to begin a trial using Oxford Nanopore's MinION to diagnose pneumonia, according to the Telegraph.
The tool has been applied to determine the pathogenic cause of hemorrhagic fever, and is powering a new test for respiratory disease pathogens.
The approach is based on a new approval of the BacT/ALERT Virtuo system and new indications for the firm's procalcitonin assay.
For the 40-target panel, the trial found an overall average weighted sensitivity and specificity of 90 and 99 percent, respectively.
In PLOS this week: genetic networks involved in antibiotic sensitivity, syphilis pathogen proteome, and more.
The test is an improved version of one that was approved three years ago, and runs on the firm's illumigene molecular diagnostics platform.
In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.
An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.
In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.
In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.